Arch Biopartners’ Cilastatin Drug Candidate to Participate
Arch is repurposing cilastatin, a dipeptidase-1 inhibitor, as a new treatment for acute kidney injury (AKI)Cilastatin is particularly well suited ...
Read more
ADVERTISEMENT
ADVERTISEMENT
Tag: Biopartners
Arch Biopartners Arranges Non-Brokered Private Placement
TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) ...
Read more
Recent News
LifeCare News is a registered magazine in RNI (Registrar of Newspapers for India) is started in 2015, as well as Lifecarenews have a malti language portal. Life Care News portal was connected with many reputed news agency.